<DOC>
	<DOCNO>NCT01026831</DOCNO>
	<brief_summary>This study compare safety efficacy preservative-free formulation 0.0015 % MK2452 ( tafluprost ) preservative-free 0.5 % timolol maleate patient open-angle glaucoma ocular hypertension . This study demonstrate preservative-free formulation 0.0015 % tafluprost non-inferior preservative-free 0.5 % timolol maleate .</brief_summary>
	<brief_title>Preservative-Free MK2452 ( Tafluprost ) Open-Angle Glaucoma/Ocular Hypertension ( MK2452-001 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Patient diagnose primary openangle glaucoma , pigmentary glaucoma , capsular glaucoma/pseudoexfoliation , ocular hypertension Patient mean ( median ) IOP &gt; =23 = &lt; 36 least one eye 0800 hour time point Baseline Visit . Patient &lt; 5 mmHg difference mean ( median ) IOP eyes time point ( 0800 hour , 1000 hour , 1600 hour ) Baseline . Patient currently use prescribe ocular hypotensive medication stable dose 30 day prior screen , patient drugnaive ( never use use ocular hypotensive medication least 4 week prior screen ) Patient able safely discontinue current ocular hypotensive medication 4week washout period Patient vision correct 20/80 good eye Patient willing able avoid wear contact lens 4 week prior dose 24 hour final dosing Patient willing able selfadminister able person available daily basis assist administration study medication Patient pregnant planning become pregnant study Patient male female ≥18 age day sign informed consent Patient unable use study medication affect eye ( ) Patient history inflammatory ocular surface disease anterior posterior uveitis either eye Patient history retinal detachment , diabetic retinopathy , progressive retinal disease Patient experience significant visual field loss within last year Patient intraocular surgery either eye last 4 month Patient history glaucoma surgery refractive surgery either eye Patient currently take two antiglaucoma medication ( except Cosopt™ generic formulation ) Patient previously use tafluprost Patient history cardiovascular disorder within 6 month prior screen Patient history bronchial asthma , wheeze , pneumonia , COPD , pulmonary disease , abnormal chest xray Patient mean ( median ) IOP &gt; 36 mmHg either eye Screening Visit time point ( 0800 hour , 1000 hour , 1600 hour ) Baseline Visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>